MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Scales"

  • MDS Virtual Congress 2020

    Long-term course and confounding factors of MDS-UPDRS in a longitudinal single-center (DeNoPa) and a multicenter cohort (PPMI)

    M. Bartl, M. Dakna, S. Schade, E. Lang, C. Trenkwalder, B. Mollenhauer (Göttingen, Germany)

    Objective: To systematically compare long-term course of Parkinson's disease (PD) by the MDS-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) and investigate possible predictive parameters of different…
  • MDS Virtual Congress 2020

    Association between actively and passively monitored hand gestures in early Parkinson’s disease

    E. Volkova-Volkmar, A. Thomann, B. van Lier, D. Wolf, G. Pointeau, Y.P Zhang Schärer, W.Y Cheng, C. Simillion, G. Pagano, W. Zago, C. Gossens, F. Lipsmeier, K. Taylor, M. Lindemann (Basel, Switzerland)

    Objective: To determine the reliability and preliminary validity of passively acquired smartwatch-based sensor features of hand gestures in early Parkinson’s disease (PD). Background: Hand movements…
  • MDS Virtual Congress 2020

    The non-declaration of musculoskeletal pain in Parkinson’s disease in patient-related outcome measures –The King’s experience

    K. Rukavina, M. Krbot Skoric, C. Borley, L. Batzu, A. Rizos, D. van Wamelen, K. Ray Chaudhuri (London, United Kingdom)

    Objective: To determine the usefulness of patient related outcome (PRO) measures in highlighting non-declaration of pain, a challenging non-motor symptom (NMS) of Parkinson’s disease (PD).…
  • MDS Virtual Congress 2020

    Quantitative extremity movement measurement

    J. Brasic, T. Harrigan, B. Hwang, K. Mills, A. Pantelyat, J. Bang, A. Syed, P. Vyas, S. Martin, A. Jamal, R. Panaparambil, A. Gaite, L. Ziegelman, M. Hernandez (Baltimore, MD, USA)

    Objective: To demonstrate the feasibility of a simple low-cost procedure to quantitatively measure movements in the extremities of people with Parkinson's disease and other movement…
  • MDS Virtual Congress 2020

    Video-based computer vision system exhibits concurrent validity with clinical ratings of head tremor severity in cervical dystonia

    J. Vu, L. Le, X. Guo, R. Rouzbehani, D. Sy, R. Elble, G. Stebbins, C. Comella, D. Peterson (La Jolla, CA, USA)

    Objective: Our objective was to develop and test the concurrent validity of CMOR (Computational Motor Objective Rater; a computer vision-based software system) to quantify HT…
  • MDS Virtual Congress 2020

    Phenotype of Parkinson’s Disease in African Americans Using NIH Toolbox Motor Measures

    M. Bailey, G. Stebbins, S. Anderson, D. Hall (Chicago, IL, USA)

    Objective: To determine phenotypic differences using qualitative and quantitative measures between African American (AA) and white (W) patients with Parkinson’s disease (PD) at Rush University…
  • MDS Virtual Congress 2020

    Clinical Dementia Rating Scale Sum of Boxes (CDR-SOB) in Parkinson’s Disease: Longitudinal Results

    J. Gallagher, J. Rick, S. Xie, E. Mamikonyan, B. Deck, S. Rudovsky, A. Chen-Plotkin, N. Dahodwala, J. Morley, J. Duda, J. Trojanowski, D. Weintraub (Philadelphia, PA, USA)

    Objective: To assess the change over time (1-2 years) on the Clinical Dementia Rating Sum of Boxes (CDR-SOB) in Parkinson's disease (PD). Background: The CDR-SOB…
  • MDS Virtual Congress 2020

    Sustained Improvement in Freezing of Gait (FOG) and Treatment Satisfaction at 12 months After Initiation of Carbidopa/Levodopa Enteral Suspension (CLES) in Advanced Parkinson’s Disease (APD) Patients in USA: Interim Results from the PROviDE Study

    R. Pahwa, S. Isaacson, B. Bluett, P. Kandukuri, N. Gupta, Y. Jalundhwala, P. Kukreja, I. Pan, J. Aldred (North Chicago, IL, USA)

    Objective: To evaluate the long-term effectiveness of CLES on FOG and treatment satisfaction in APD patients. Background: FOG, prevalent in about 60% of APD patients,…
  • MDS Virtual Congress 2020

    Improving Diagnosis and Treatment of Anxiety in Parkinson’s Disease: IDATA-PD Study Update

    N. Dissanayaka, G. Byrne, L. Mitchell, J. O'Sullivan, A. Padmassini, E. White, J. Yang, E. Forbes, K. Thangavelu, T. Au, A. Lehn, R. Adam, N. Pachana (Brisbane, Australia)

    Objective: 1. To develop an inventory to assess Parkinson’s disease (PD) specific anxiety for person centred psychotherapy interventions. 2. To develop manualised cognitive behaviour therapy…
  • MDS Virtual Congress 2020

    Measure of Social Relation in Huntington’s Disease: The Relationship Self-Questionnaire (RSQ)

    J. Hamet Bagnou, R. Massart, K. Hernandez, R. Fliss, M. Lunven, E. Audureau, A.C Bachoud-Levi (Creteil, France)

    Objective: Development and validation of the Relationship Self-Questionnaire (RSQ), specific to Huntington’s disease (HD), which aims tomeasurepatients self-perceived quality of their relationships (RS). Background: In…
  • « Previous Page
  • 1
  • …
  • 18
  • 19
  • 20
  • 21
  • 22
  • …
  • 35
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #28953 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley